46 Chapter 2 21. Cadigan, K. M. and Waterman, M. L. (2012). TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harbor Perspect. Biol. 4, a007906. 22. Calpe, B. and Kovacs, W. J. (2020). High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment. Exp. Opin. Drug Discov. 15, 955-967. 23. Castellan, R. F. P., Thomson, A., Moran, C. M. and Gray, G. A. (2020). Electrocardiogram-gated Kilohertz Visualisation (EKV) Ultrasound allows assessment of neonatal cardiac structural and functional maturation and longitudinal evaluation of regeneration after injury. Ultrasound Med. Biol. 46, 167-179. 24. Chan, S. S., Shi, X., Toyama, A., Arpke, R. ÂW., Dandapat, A., Iacovino, M., Kang, J., Le, G., Hagen, H. ÂR., Garry, D. ÂJ. et al. (2013). Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell 12, 587-601. 25. Chattergoon, N. N., Louey, S., Scanlan, T., Lindgren, I., Giraud, G. D. and Thornburg, K. L. (2019). Thyroid hormone receptor function in maturing ovine cardiomyocytes. J. Physiol. 597, 2163-2176. 26. Colucci, W. S. (1997). Molecular and cellular mechanisms of myocardial failure. Am. J. Cardiol. 80, 15L-25L. 27. Cook, J. A., Shah, K. B., Quader, M. A., Cooke, R. H., Kasirajan, V., Rao, K. K., Smallfield, M. C., Tchoukina, I. and Tang, D. G. (2015). The total artificial heart. J. Thorac. Dis. 7, 2172-2180. 28. De Bakker, B. S., De Jong, K. H., Hagoort, J., De Bree, K., Besselink, C. T., De Kanter, F. E. C., Veldhuis, T., Bais, B., Schildmeijer, R., Ruijter, J. M. et al. (2016). An interactive three-dimensional digital atlas and quantitative database of human development. Science 354, aag0053. 29. De Boer, R. A., Pinto, Y. and Van Veldhuisen, D. (2003). The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 10, 113-126. 30. De Boer, B. A., Van Den Berg, G., De Boer, P. A. J., Moorman, A. F. M. and Ruijter, J. M. (2012). Growth of the developing mouse heart: an interactive qualitative and quantitative 3D atlas. Dev. Biol. 368, 203-213. 31. De Jong, F., Opthof, T., Wilde, A. A., Janse, M. J., Charles, R., Lamers, W. H. and Moorman, A. F. (1992). Persisting zones of slow impulse conduction in developing chicken hearts. Circ. Res. 71, 240-250. 32. Debosch, B., Treskov, I., Lupu, T. S., Weinheimer, C., Kovacs, A., Courtois, M. and Muslin, A. J. (2006). Akt1 is required for physiological cardiac growth. Circulation 113, 2097-2104. 33. Del Re, D. P. (2014). The hippo signaling pathway: implications for heart regeneration and disease. Clin. Transl. Med. 34. Dhanantwari, P., Lee, E., Krishnan, A., Samtani, R., Yamada, S., Anderson, S., Lockett, E., Donofrio, M., Shiota, K., Leatherbury, L. et al. (2009). Human cardiac development in the first trimester: a high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas. Circulation 120, 343-351. 35. Dıaz Del Moral, S., Benaouicha, M., Mun ́ oz-Chapuli, R. and Carmona, R. (2021). The insulin-like growth factor signalling pathway in cardiac development and regeneration. Int. J. Mol. Sci. 23, 234 36. Diez-Cun ado, M., Wei, K., Bushway, P. J., Maurya, M. R., Perera, R., Subramaniam, S., Ruiz-Lozano, P. and Mercola, M. (2018). miRNAs that induce human cardiomyocyte proliferation converge on the hippo pathway. Cell Rep. 23, 2168 37. Drenckhahn, J., Schwarz, Q. P., Gray, S., Laskowski, A., Kiriazis, H., Ming, Z., Harvey, R. P., Du, X.-J., Thorburn, D. R. and Cox, T. C. (2008). Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev. Cell 15, 521-533. 38. Faber, J. W., Hagoort, J., Moorman, A. F. M., Christoffels, V. M. and Jensen, B. (2021). Quantified growth of the human embryonic heart. Biol. Open 10, bio057059. 39. Fan, C., Oduk, Y., Zhao, M., Lou, X., Tang, Y., Pretorius, D., Valarmathi, M. T., Walcott, G. P., Yang, J., Menasche, P. et al. (2020). Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1. JCI Insight 5, e132796. 40. Fassina, D., Costa, C. M., Longobardi, S., Karabelas, E., Plank, G., Harding, S. E. and Niederer, S. A. (2022). Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design. PLoS Comput. Biol. 18, e1010030. 41. Fox, K. F., Cowie, M. R., Wood, D. A., Coats, A. J., Gibbs, J. S., Underwood, S. R., Turner, R. M., Poole-Wilson, P. A., Davies, S. W. and Sutton, G. C. (2001). Coronary artery disease as the cause of incident heart failure in the population. Eur. Heart J. 22, 228-236.
RkJQdWJsaXNoZXIy MTk4NDMw